Nanotechnology RSS feeds


ENJOY THE BENEFITS

Simply Register to GAIN ACCESS to lots more info

USER LOGIN

NANOTECHNOLOGY FACTS ...

...Nanometres...
nanotechnology companies | nanotechnology info Human hair 80,000 nm wide
nanotechnology companies | nanotechnology info Red blood cell 7,000 nm wide
nanotechnology companies | nanotechnology info Water molecule 0.3 nm wide

SALES & WANTED

nanotechnology companies | nanotechnology infoNano Silver Powder
nanotechnology companies | nanotechnology infoFree Green Engine Oil

-----
What have you? - Place your ads here for FREE - *APPLY*

LATEST MEMBERS

  • Envirodiamond T...
  • anjumittal1
  • John Wong
  • t2.net
  • Pankaj Madkikar
  • rezasafa

WHO'S ONLINE

There are currently 0 users and 12 guests online.

  Valid XHTML 1.0 Transitional

Button for your site

news aggregator

Nanotechnology to kill bacteria OK in hospitals but suspect in commercial products

Foresight - 1 hour 38 min ago

There is hope that nanotechnology in the form of silver nanoparticles will provide protection against drug-resistant bacteria in hospitals, but there is also concern that unregulated use of silver nanoparticles in commercial products will damage the environment. A mention on KurzweilAI.net led to this article by Monica Heger on SciAm.com News, provided originally by Scienceline. From “A Silver Coating in the Fight Against Microbes“:

A new technique in paint making could soon make almost any surface germ-free. Researchers have made paint that is embedded with silver nanoparticles, known for their ability to kill bacteria and other microbes, in the hopes that hospitals will coat their walls and countertops to fight infection.

According to the U.S. Centers for Disease Control and Prevention, more than 1 million people per year contract bacterial infections in hospitals. Silver itself is an excellent bacteria fighter, and in nanoparticle form it is even more potent at killing microorganisms. So far it has not shown any adverse effects in humans.

However, some scientists are concerned that silver nanoparticles may not be as harmless as they appear. Little research has been done on their health and environmental effects, and silver kills good microorganisms along with the bad. Also, there are currently no restrictions on using silver nanoparticles, which are already popping up in a range of consumer products that tout their antibacterial properties.

“Nanoparticles are very small and they are interacting with the bacteria and rupturing the cell wall,” says chemist George John of City College of New York and lead author of the study, published in the journal Nature Materials [abstract] last month. This rupturing kills the bacteria, he explains.

A silver nanoparticle is a small cluster of silver atoms less than 100 nanometers, or 100 billionths of a meter, wide. Because of their size, nanoparticles exhibit different properties than their bulkier counterparts. They have a high surface area to volume ratio, which makes them able to dissolve in paint. Nanoparticles are also being studied for their use in medicine, particularly in drug delivery, since they are able to pass easily through cell membranes.

…”It is more or less like a soaping or detergent effect,” says Lucian Lucia, associate professor of chemistry at North Carolina State University. The nanoparticle destroys the cell wall of the microbe.

Lucia and John both agree that bacteria cannot build up a resistance to silver nanoparticles as they can to antibiotics, because of the way the silver nanoparticle attacks — destroying the structure of the cells and killing them. Antibiotics, on the other hand, suppress the activity of bacteria but don’t necessarily kill them. “That’s the beauty of silver,” Lucia says. “There’s no way to develop a resistance to it.”

…Andrew Maynard, the chief science advisor for the Project on Emerging Nanotechnologies, funded by the Woodrow Wilson International Center for Scholars and the Pew Charitable Trust, is … concerned about the lack of research and regulation on the use of silver nanoparticles. He says this technology is cropping up in unlikely products, like socks, kitchenware and cosmetics, to name a few.

“You have an anti-microbial agent appearing everywhere, including children’s fluffy toys, with no knowledge about its health or environmental implications,” Maynard says. “What are the chances of it taking out an ecologically important bacteria?”

And it is this question that Maynard wants answered before the technology is applied to any more commercial products. On the other hand though, Maynard acknowledges that the use of silver nanoparticles holds promise, particularly in hospital settings.

—Jim

Extreme DA -- The Technology Leader in IC Timing Analysis -- Expands Management Team

Business Wire - 1 hour 57 min ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Extreme DA has promoted two founding executives and hired two directors to lead the company’s development of new

Nanomedicine company Nanobiotix elects former Aventis vice chairman and CFO Patrick Langlois as its chairman

Business Wire - 1 hour 57 min ago
PARIS--(BUSINESS WIRE)--Nanobiotix, an emerging nanomedicine company focused on cancer therapy, announced

HelioVolt Exceeds 12% Solar Thin Film Efficiency with Rapid, Scalable Printing Process

Business Wire - 1 hour 57 min ago
SAN DIEGO--(BUSINESS WIRE)--In results presented at the IEEE Photovoltaic Specialists Conference, HelioVolt Corporation announces that its proprietary FASST®

Analyse Nanobiotechnologies: Applications, Markets and Companies

Business Wire - 1 hour 57 min ago
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c10618)

Applied Materials Announces Powerful SunFab Performance Service; Signs Multiyear Agreement with T-Solar

Business Wire - 1 hour 57 min ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Applied Materials, Inc. today announced another first for the solar industry with its SunFab Performance Service

Comprehensive Overview of All Major Nanostructured Materials

Business Wire - 1 hour 57 min ago
DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/reports/c91350)

Luminus Devices Wins SBANE 2008 Innovation Award

Business Wire - 1 hour 57 min ago
BILLERICA, Mass.--(BUSINESS WIRE)--Luminus Devices, Inc., the developer and manufacturer of PhlatLight® (Photonic Lattice) LED products for a

More Than 550 Million GPS-Enabled Handsets Will Ship by 2012, Says ABI Research

Business Wire - 1 hour 57 min ago
LONDON--(BUSINESS WIRE)--In the wake of personal navigation devices’ success, cellular carriers have started to offer on-board and off-board navigation

Magnolia Optical Technologies is Part of the Kopin Led Team Selected for Award of NASA Solar Cell Development Contract

Business Wire - 1 hour 57 min ago
WOBURN, Mass.--(BUSINESS WIRE)--Magnolia Optical Technologies, Inc. announced today that it is part of the Kopin Corporation team that has been selected for the award of a solar cell

Harris & Harris Group Reports Financial Statements as of March 31, 2008

Business Wire - 1 hour 57 min ago
NEW YORK--(BUSINESS WIRE)--Harris & Harris Group, Inc., reported today that, as of March 31, 2008, its net asset value and its net asset value per share (NAV) were $136,541,289 and

Luna Innovations Reports First Quarter 2008 Financial Results

Business Wire - 1 hour 57 min ago
ROANOKE, Va.--(BUSINESS WIRE)--Luna Innovations Incorporated (NASDAQ:LUNA) today announced its financial results for its first quarter ended March 31, 2008.

DECT Forum Announces International CAT-iq Design Competition

Business Wire - 1 hour 57 min ago
BERNE, Switzerland--(BUSINESS WIRE)--The DECT Forum, the worldwide association of the wireless communication industry, in partnership with the market intelligence company Jakajima in the

EMD Chemicals to Open New Materials Science Research Lab in Cambridge, MA

Business Wire - 1 hour 57 min ago
GIBBSTOWN, N.J.--(BUSINESS WIRE)--EMD Chemicals Inc., a subsidiary of Merck KGaA of Germany, announced today that it will open a new research and development laboratory in Cambridge,

pSivida Announces Start of Clinical Trial to Assess Safety and Efficacy of Medidur(TM) FA in Patients with Age Related Macular Degeneration Treated with Lucentis(R)

Business Wire - 1 hour 57 min ago
BOSTON & PERTH, Australia--(BUSINESS WIRE)--pSivida Limited (NASDAQ:PSDV)(ASX:PSD)(FSE:PSI) announced today that enrollment has begun for a clinical trial to assess the safety and efficacy

Applied Materials Ships 200th Producer APF System, the CVD Patterning Technology of Choice for Advanced Device Scaling

Business Wire - 1 hour 57 min ago
SANTA CLARA, Calif.--(BUSINESS WIRE)--Applied Materials, Inc. announced the shipment of its 200th Applied Producer APF

Nanogen to Host First Quarter Conference Call May 12, 2008

Business Wire - 1 hour 57 min ago
SAN DIEGO--(BUSINESS WIRE)--Nanogen, Inc. (Nasdaq:NGEN), developer of innovative, high-quality diagnostic products, will host a conference call on Monday, May 12, 2008 at 4:30 p.m. Eastern

Clean Technology 2008 Announces More Early Stage Company Presentation Selections

Business Wire - 1 hour 57 min ago
BOSTON--(BUSINESS WIRE)--NSTI.org, producer of Clean Technology 2008, today announced its Early Stage Ventures Conference Program to be held in Massachusetts at the Hynes Convention Center,

SEMATECH to Hold Workshops on Developments in EUV Source Technology and Forward Thinking Solutions for Optical Lithography

Business Wire - 1 hour 57 min ago
ALBANY, N.Y.--(BUSINESS WIRE)--SEMATECH, a pioneering research consortium of leading semiconductor manufacturers, will hold two workshops to guide critical thinking on extending the

Toppan Printing Receives 'Supplier Excellence Award' From Texas Instruments

Business Wire - 1 hour 57 min ago
TOKYO--(BUSINESS WIRE)--Toppan Printing’s Semiconductor Solutions Division announced today that it has received a Texas Instruments (TI)
                                                                                                                                                                                                                                                                                          
Back to previous page Go to the top of this page